PharmaCorp Rx's total inventories for the quarter that ended in Mar. 2026 was C$3.05 Mil. PharmaCorp Rx's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was C$2.88 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. PharmaCorp Rx's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was C$0.09.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PharmaCorp Rx's Days Inventory for the
three
months ended in Mar. 2026 was 59.76.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PharmaCorp Rx's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.53.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PharmaCorp Rx's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.40.
PharmaCorp Rx (TSXV:PCRX) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
PharmaCorp Rx's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PharmaCorp Rx's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
PharmaCorp Rx Total Inventories Related Terms
PharmaCorp Rx Total Inventories Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
PharmaCorp Rx (TSXV:PCRX) has a Total Inventories of C$3.05 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Total Inventories too high?
PharmaCorp Rx's current Total Inventories is C$3.05 Mil. Overall, PharmaCorp Rx has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Total Inventories compare to competitors?
PharmaCorp Rx's Total Inventories of C$3.05 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for PharmaCorp Rx and its competitors. PharmaCorp Rx's current Total Inventories is C$3.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Total Inventories of C$3.05 Mil. The current Total Inventories is C$3.05 Mil. PharmaCorp Rx's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Total Inventories is C$3.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
36GF Score
Get the complete analysis for TSXV:PCRX
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
